Position
Fidelity in Emergent BioSolutions Inc.
Back to the book · All holders of EBS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $12.3K$8.30 → $8.38
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 118.3K | $1.46M | — | — | — | 0.0% |
| Q1 2026 | 153.9K | $1.28M | $8.30 | −$480.3K | $295.3K | 0.0% |
| Q2 2026 | 214.2K | $1.79M | $8.38 | $12.3K | $505.2K | 0.0% |